PL2729473T3 - Pochodne kwasu karboksylowego z pierścieniem oksazolo[5,4-B]pirydynowym - Google Patents

Pochodne kwasu karboksylowego z pierścieniem oksazolo[5,4-B]pirydynowym

Info

Publication number
PL2729473T3
PL2729473T3 PL12733131T PL12733131T PL2729473T3 PL 2729473 T3 PL2729473 T3 PL 2729473T3 PL 12733131 T PL12733131 T PL 12733131T PL 12733131 T PL12733131 T PL 12733131T PL 2729473 T3 PL2729473 T3 PL 2729473T3
Authority
PL
Poland
Prior art keywords
oxazolo
carboxylic acid
acid derivatives
pyridine ring
pyridine
Prior art date
Application number
PL12733131T
Other languages
English (en)
Inventor
Dieter Kadereit
Matthias Schäfer
Stephanie Hachtel
Thomas Huebschle
Katrin Hiss
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL2729473T3 publication Critical patent/PL2729473T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL12733131T 2011-07-07 2012-07-06 Pochodne kwasu karboksylowego z pierścieniem oksazolo[5,4-B]pirydynowym PL2729473T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11305877 2011-07-07
EP12305525 2012-05-11
EP12733131.2A EP2729473B1 (de) 2011-07-07 2012-07-06 Carbonsäurederivate mit einem oxazolo[5,4-b]pyridinring
PCT/EP2012/063297 WO2013004826A1 (de) 2011-07-07 2012-07-06 Carbonsäurederivate mit einem oxazolo[5,4-b]pyridinring

Publications (1)

Publication Number Publication Date
PL2729473T3 true PL2729473T3 (pl) 2016-05-31

Family

ID=46466551

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12733131T PL2729473T3 (pl) 2011-07-07 2012-07-06 Pochodne kwasu karboksylowego z pierścieniem oksazolo[5,4-B]pirydynowym

Country Status (20)

Country Link
US (1) US8580816B2 (pl)
EP (1) EP2729473B1 (pl)
JP (1) JP5984925B2 (pl)
KR (1) KR20140061384A (pl)
CN (1) CN103781790B (pl)
AU (1) AU2012280206B2 (pl)
BR (1) BR112014000100A2 (pl)
CA (1) CA2841220C (pl)
CY (1) CY1117390T1 (pl)
DK (1) DK2729473T3 (pl)
ES (1) ES2562852T3 (pl)
HR (1) HRP20160167T1 (pl)
HU (1) HUE026432T2 (pl)
MX (1) MX365931B (pl)
MY (1) MY164133A (pl)
PL (1) PL2729473T3 (pl)
PT (1) PT2729473E (pl)
RU (1) RU2609002C2 (pl)
SI (1) SI2729473T1 (pl)
WO (1) WO2013004826A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO143535C (no) * 1972-06-14 1981-03-04 Merck & Co Inc Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxazolopyridiner
PT1390371E (pt) * 2001-05-14 2006-07-31 Novartis Ag Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
EP1638551B1 (en) * 2003-05-19 2011-12-21 Irm Llc Immunosuppressant compounds and compositions
EP1965807A4 (en) * 2005-11-23 2010-10-27 Epix Delaware Inc S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE
EP1900729A1 (en) * 2006-09-15 2008-03-19 Novartis AG Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
CA2679980A1 (en) 2007-03-21 2007-09-27 Epix Pharmaceuticals, Inc. S1p receptor modulating compounds and use thereof
EP2300481B1 (en) 2008-05-30 2015-09-30 Merck Sharp & Dohme Corp. Novel substituted azabenzoxazoles
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
BRPI0915781A2 (pt) 2008-07-15 2015-11-10 Sanofi Aventis oxazolopiridimas como agonista do receptor edg-1
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring

Also Published As

Publication number Publication date
BR112014000100A2 (pt) 2017-01-10
CA2841220C (en) 2019-07-30
EP2729473B1 (de) 2015-11-25
CN103781790A (zh) 2014-05-07
RU2014104232A (ru) 2015-08-20
KR20140061384A (ko) 2014-05-21
HRP20160167T1 (hr) 2016-03-11
EP2729473A1 (de) 2014-05-14
WO2013004826A1 (de) 2013-01-10
CN103781790B (zh) 2016-04-27
HK1192239A1 (zh) 2014-08-15
ES2562852T3 (es) 2016-03-08
MY164133A (en) 2017-11-30
US8580816B2 (en) 2013-11-12
PT2729473E (pt) 2016-03-22
US20130023557A1 (en) 2013-01-24
MX2014000024A (es) 2014-02-27
DK2729473T3 (en) 2016-02-29
SI2729473T1 (sl) 2016-03-31
CA2841220A1 (en) 2013-01-10
MX365931B (es) 2019-06-20
JP2014518247A (ja) 2014-07-28
AU2012280206A1 (en) 2014-01-23
HUE026432T2 (en) 2016-05-30
AU2012280206B2 (en) 2016-07-28
RU2609002C2 (ru) 2017-01-30
JP5984925B2 (ja) 2016-09-06
CY1117390T1 (el) 2017-04-26

Similar Documents

Publication Publication Date Title
IL227496B (en) Pyrazolo[4,3–b]pyridines are converted as drugs
ZA201307783B (en) Tri-and tetracylic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
ZA201306542B (en) 7-azaindole derivatives
IL235819A0 (en) Preparation of pyrrolo[b–3,2]pyridines
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
EP2634186A4 (en) naphthyridine
LT2740476T (lt) Cis-tetrahidro-spiro(cikloheksan-1,1`-pirido[3,4-b]indol)-4-amino dariniai
ZA201307511B (en) Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
IL232717B (en) 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
ZA201301313B (en) Herbicidal isoxazolo[5,4-b]pyridines
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
PL2776431T3 (pl) Stanowiące antybiotyki pochodne 2-okso-oksazolidyno-3,5-diylu
IL232916A (en) 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine
SG11201408816QA (en) 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
DK2523958T3 (da) Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring
ZA201304074B (en) Pyrazino[2,3-d]isoxazole derivative
ZA201308497B (en) 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
PT2729471E (pt) Derivados do ácido carboxílico com um anel de oxazolo[5,4-d pirimidina
PL2729473T3 (pl) Pochodne kwasu karboksylowego z pierścieniem oksazolo[5,4-B]pirydynowym
BR112013013282A2 (pt) compostos de oxazolo[5,4-b]piridin-5-ila
EP2565194A4 (en) IMIDAZO [1,2-a] PYRIDINE DERIVATIVE
IL228270A0 (en) History of 1-h- pyrrolidine -4,2-dione spirocyclics converted in cis-alkoxy
PT2729475E (pt) Derivados do ácido carboxílico com um anel de oxazolo[4,5-d pirimidina